Related references
Note: Only part of the references are listed.Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors
Andrew C. Dudley et al.
BLOOD (2010)
Endothelial Progenitor Cells: Hope Beyond Controversy
E. Pasquier et al.
CURRENT CANCER DRUG TARGETS (2010)
Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos
Alexandre Trindade et al.
BLOOD (2008)
Inducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice
Urban Deutsch et al.
EXPERIMENTAL CELL RESEARCH (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Notch Pathway Modulation on Bone Marrow-Derived Vascular Precursor Cells Regulates Their Angiogenic and Wound Healing Potential
Francisco Caiado et al.
PLOS ONE (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis
Jonathan D. Leslie et al.
DEVELOPMENT (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition
Henk. M. W. Verheul et al.
NATURE REVIEWS CANCER (2007)
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera-Troise et al.
NATURE (2006)
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
John Ridgway et al.
NATURE (2006)
Targeted therapy for metastatic renal cell carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function
CK Williams et al.
BLOOD (2006)
Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function
NS Patel et al.
CANCER RESEARCH (2005)
Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis
MT Huang et al.
BLOOD (2005)
Contribution of bone marrow-derived endothelial cells to human tumor vasculature
BA Peters et al.
NATURE MEDICINE (2005)
Minimal contribution of marrow-derived endothelial precursors to tumor vasculature
B Larrivee et al.
JOURNAL OF IMMUNOLOGY (2005)
Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development
NW Gale et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
J Oliner et al.
CANCER CELL (2004)
Dosage-sensitive requirement for mouse D114 in artery development
A Duarte et al.
GENES & DEVELOPMENT (2004)
Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization
J Yamaguchi et al.
CIRCULATION (2003)
Vascular and haematopoietic stem cells:: Novel targets for anti-angiogenesis therapy?
S Rafii et al.
NATURE REVIEWS CANCER (2002)
Delta4, an endothelial specific Notch ligand expressed at sites of physiological and tumor angiogenesis
C Mailhos et al.
DIFFERENTIATION (2001)
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
D Lyden et al.
NATURE MEDICINE (2001)
Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium
H Uyttendaele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model
KA Scott et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
